Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRO
Marathon Oil Corporation
MRO
|
+$180M |
| 2 |
BHI
Baker Hughes
BHI
|
+$173M |
| 3 |
Dominion Energy
D
|
+$161M |
| 4 |
Kinder Morgan
KMI
|
+$155M |
| 5 |
Marathon Petroleum
MPC
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRX
FOREST LABORATORIES INC
FRX
|
+$177M |
| 2 |
SLB Ltd
SLB
|
+$121M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$119M |
| 4 |
PepsiCo
PEP
|
+$110M |
| 5 |
Mastercard
MA
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 15.14% |
| 2 | Healthcare | 12.64% |
| 3 | Financials | 8.59% |
| 4 | Utilities | 7.75% |
| 5 | Technology | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UFS
1301
DELISTED
DOMTAR CORPORATION (New)
UFS
| $4.9M | 0.01% |
139,515
-77,661
| -36% | -$2.96M |
|
1302
Toll Brothers
TOL
$13.6B
| $4.87M | 0.01% |
156,225
+145,064
| +1,300% | +$4.97M |
|
1303
Willis Towers Watson
WTW
$32.6B
| $4.86M | 0.01% |
44,356
+42,281
| +2,038% | +$4.7M |
|
|
FNGN
1304
DELISTED
Financial Engines, Inc.
FNGN
| $4.85M | 0.01% |
141,786
+84,948
| +149% | +$3.13M |
|
1305
CNA Financial
CNA
$13.4B
| $4.85M | 0.01% |
127,433
-15,994
| -11% | -$619K |
|
|
GEVA
1306
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $4.84M | 0.01% |
+70,423
| New | +$5.04M |
|
1307
Vipshop
VIPS
$6.88B
| $4.84M | 0.01% |
+255,940
| New | +$5.27M |
|
1308
Stepan Co
SCL
$1.41B
| $4.84M | 0.01% |
108,980
+48,992
| +82% | +$2.4M |
|
|
NSTG
1309
DELISTED
NanoString Technologies, Inc.
NSTG
| $4.83M | 0.01% |
441,835
+132,887
| +43% | +$1.64M |
|
|
BRCD
1310
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $4.83M | 0.01% |
444,016
-773,520
| -64% | -$7.53M |
|
|
ECYT
1311
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $4.82M | 0.01% |
792,093
+509,705
| +180% | +$3.48M |
|
1312
RB Global
RBA
$15.6B
| $4.81M | 0.01% |
+215,005
| New | +$5.13M |
|
1313
PUT
D.R. Horton
DHI
$41.7B
| $4.8M | 0.01% |
234,100
| – | – |
|
1314
CME Group
CME
$100B
| $4.8M | 0.01% |
60,000
-300
| -0.5% | -$22.6K |
|
|
MENT
1315
DELISTED
Mentor Graphics Corp
MENT
| $4.79M | 0.01% |
233,823
-49,842
| -18% | -$1.06M |
|
1316
iShares China Large-Cap ETF
FXI
$4.24B
| $4.79M | 0.01% |
+125,000
| New | +$5.01M |
|
|
CIM
1317
Chimera Investment
CIM
$973M
| $4.77M | 0.01% |
104,641
+17,169
| +20% | +$827K |
|
1318
CALL
Microsoft
MSFT
$3.62T
| $4.77M | 0.01% |
102,900
-30,500
| -23% | -$1.36M |
|
|
PX
1319
DELISTED
Praxair Inc
PX
| $4.76M | 0.01% |
36,916
-236,282
| -86% | -$31M |
|
1320
Automatic Data Processing
ADP
$112B
| $4.75M | 0.01% |
65,110
+57,820
| +793% | +$4.18M |
|
|
BLUE
1321
DELISTED
bluebird bio
BLUE
| $4.75M | 0.01% |
10,218
-703
| -6% | -$324K |
|
|
TRAK
1322
DELISTED
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
| $4.74M | 0.01% |
109,150
-255,428
| -70% | -$10.8M |
|
1323
Goodyear
GT
$1.73B
| $4.74M | 0.01% |
209,713
-20,152
| -9% | -$517K |
|
1324
CALL
Newmont
NEM
$139B
| $4.71M | 0.01% |
204,400
-149,100
| -42% | -$3.8M |
|
1325
Vanguard Real Estate ETF
VNQ
$39.3B
| $4.71M | 0.01% |
65,488
+49,037
| +298% | +$3.7M |
|
Similar funds
Israel Englander's Q3 2014 Portfolio in Review
As of Q3 2014, Israel Englander held 4,400 positions worth $39.5B, up 9.5% from $36.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander deployed $4.94B of net new capital in Q3 2014, opening 1,066 new positions and adding to 1,336 existing holdings. Its largest new stake was St Jude Medical: 1,407,737 shares worth $84.6M.
By sector, the portfolio is most concentrated in Energy at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was SLB Ltd, an estimated $121M trimmed.
- Israel Englander's largest Q3 2014 buy was St Jude Medical: 1,407,737 shares worth $84.6M.
- Israel Englander added most to Marathon Oil Corporation in Q3 2014, an estimated $180M increase.
- Israel Englander's biggest Q3 2014 reduction was SLB Ltd, cutting an estimated $121M.
- Israel Englander fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 11% of its $39.5B portfolio in Q3 2014.
- Israel Englander opened 1,066 new positions and closed 749 in Q3 2014.
- Israel Englander's portfolio value rose 9.5% quarter-over-quarter to $39.5B.
Based on Millennium Management's 13F filing for Q3 2014, filed 14 Nov 2014.